Metformin for PCOS: Compassionate Use, Expanded Access, and How to Get It Cheaper

Import from '@womanrx/ui'

Metformin for PCOS: Compassionate Use, Expanded Access, and How to Get It Cheaper

At a glance

  • Drug / formulation / Metformin extended-release (ER), generic
  • Typical dose range for PCOS / 500 mg to 2,000 mg daily, taken with food
  • Average retail price without insurance / $10, $30/month for generic ER
  • GoodRx or Mark Cuban Cost Plus price / as low as $4, $9/month at major chains
  • HSA/FSA eligible / Yes, when prescribed by a clinician
  • Pregnancy safety / Used in PCOS-related infertility; discuss continuation with your provider at positive pregnancy test
  • Life stages most affected / Reproductive years, trying-to-conceive, perimenopause with metabolic changes
  • "Compassionate use" applies? / No. Metformin is widely available generic; standard access pathways apply

What "Compassionate Use" Actually Means for Metformin and PCOS

Compassionate use (formally called Expanded Access under FDA rules) is a pathway that lets patients access investigational drugs that have not yet received FDA approval. Metformin does not qualify. It has been FDA-approved for type 2 diabetes since 1994, and it has been available as a cheap generic for decades. No manufacturer holds an exclusive patent that could make you eligible for a compassionate-use program.

What women with PCOS are really searching for is not compassionate use in the regulatory sense. They are looking for ways to afford a drug their insurer may not cover for a non-diabetes diagnosis, or a way to access it without a traditional in-person appointment. Those are solvable problems, and this article walks through each one.

Why Insurers Sometimes Refuse to Cover Metformin for PCOS

Insurance companies code metformin as a diabetes drug. When your diagnosis code is polycystic ovary syndrome (PCOS, ICD-10 E28.2) rather than type 2 diabetes or prediabetes, some plans flag it as an off-label use and deny coverage. This is frustrating because ACOG Practice Bulletin 194 explicitly recognizes metformin as a first-line option for PCOS to improve metabolic and reproductive outcomes. The drug is on-guideline. The coverage gap is a billing mismatch, not a clinical one.

What "Expanded Access" Can Realistically Mean for You

Since the FDA definition does not apply here, think of "expanded access" in practical terms as any route that expands your access beyond a standard insurance-covered prescription. That includes:

  • Cash-pay discount programs (GoodRx, Mark Cuban Cost Plus Drugs, RxSaver)
  • Manufacturer or pharmacy patient assistance programs
  • Telehealth prescribing that avoids high specialist wait times
  • State pharmaceutical assistance programs
  • HSA or FSA payment

Each route is covered in the sections below.


The Real Cost of Metformin ER in 2026

Metformin ER is one of the least expensive medications you can be prescribed. The absence of patent protection means you pay only for manufacturing and dispensing.

Cash Price Without Insurance

At most major pharmacies, a 30-day supply of metformin ER 500 mg (one tablet twice daily) costs between $10 and $30 retail without any discount card. With a free GoodRx coupon, the same supply drops to $4, $9 at Walmart, Costco, or Kroger. Mark Cuban Cost Plus Drugs lists 60 tablets of metformin ER 500 mg for approximately $5 plus a small dispensing fee, shipped to your door.

With Insurance: How to Push Back on a Denial

If your insurer denies metformin for PCOS, your clinician can submit a prior authorization (PA) request citing ACOG Practice Bulletin 194 and any comorbid diagnosis that independently qualifies, such as prediabetes (ICD-10 R73.09) or insulin resistance (E11.65). A formal appeal that includes published guideline language succeeds more often than the initial request. A 2022 analysis in JAMA Internal Medicine found that about 39% of prior authorization denials that were appealed were ultimately reversed, which means appealing is worth your time.

Patient Assistance Programs

Because metformin is generic, no brand-name manufacturer runs a traditional patient assistance program for it. The cost is already so low that most programs redirect applicants to GoodRx or to state programs. If you are uninsured and the cash price is still a barrier, two routes matter:

  1. NeedyMeds.org maintains a state-by-state database of pharmaceutical assistance programs. Many state Medicaid programs cover metformin for PCOS without a diabetes diagnosis if your provider documents insulin resistance.
  2. Community health centers (federally qualified health centers, FQHCs) operate on a sliding-fee scale and can prescribe and sometimes dispense metformin at reduced or no cost. Find one at findahealthcenter.hrsa.gov.

Using HSA and FSA Funds for Metformin

Yes, you can use a health savings account (HSA) or flexible spending account (FSA) to pay for metformin when it is prescribed by a licensed clinician. The IRS defines qualified medical expenses to include prescription drugs, and metformin prescribed for PCOS meets that definition.

Here is a quick framework for making sure your HSA/FSA payment goes smoothly:

  • Get the prescription in writing. Some FSA administrators require a letter of medical necessity for off-label prescriptions. Ask your clinician to write a brief note stating that metformin is prescribed for PCOS-related insulin resistance.
  • Save the pharmacy receipt. Most FSA debit cards work directly at the pharmacy point of sale. Keep itemized receipts in case of audit.
  • Telehealth prescriptions count. A prescription written by a licensed clinician through a telehealth platform carries the same HSA/FSA eligibility as one written in person. The IRS does not require an in-person visit.
  • Over-the-counter metformin does not exist. Metformin requires a prescription in the US, so there is no gray area about eligibility.

FSA funds expire at year end under most plans (some allow a 2.5-month grace period or a $610 rollover in 2026). If you have unspent FSA dollars late in the year, a 90-day metformin supply is a straightforward eligible purchase.


Who This Is Right For and Who Should Think Twice

Metformin ER is appropriate for a wide range of women with PCOS, but the risk-benefit picture shifts meaningfully across life stages.

Reproductive-Age Women (18 to 40) With PCOS

This is the group with the most evidence. The PPCOS II trial (Legro et al., NEJM 2007) compared clomiphene, metformin, and the combination in 626 women with PCOS and found that clomiphene alone produced higher live-birth rates than metformin alone, but the combination outperformed either drug alone in certain subgroups. For women who are not actively trying to conceive, metformin lowers fasting insulin, improves menstrual regularity, and modestly reduces androgen levels.

A 2020 Cochrane review of 44 trials found that metformin improves clinical pregnancy rates compared with placebo in women with PCOS (OR 1.93, 95% CI 1.42 to 2.64), reinforcing its role in the fertility toolkit.

Women Trying to Conceive

Metformin is often continued through the first trimester in women with PCOS who conceive while taking it, particularly those with a history of early pregnancy loss or gestational diabetes risk. This is covered in detail in the pregnancy section below.

Perimenopause and Beyond

PCOS does not disappear at menopause. A 2023 study in the Journal of Clinical Endocrinology and Metabolism found that postmenopausal women with a prior PCOS diagnosis carry a significantly elevated risk of type 2 diabetes and cardiovascular disease compared with age-matched controls. Metformin may be appropriate for perimenopausal women with PCOS who show worsening insulin resistance, though evidence in this specific group is thinner and is largely extrapolated from diabetes-prevention data rather than PCOS-specific trials. If you are perimenopausal with PCOS, ask your clinician whether ongoing metformin, hormone therapy, or both make sense for your metabolic profile.

Who Should Not Use Metformin

  • Women with an eGFR <30 mL/min/1.73m² (contraindicated due to lactic acidosis risk)
  • Active or excessive alcohol use
  • Planned procedures using iodinated contrast dye (hold metformin 48 hours before and after)
  • Known hypersensitivity to metformin

Pregnancy, Lactation, and Contraception

Pregnancy and lactation guidance is mandatory for any drug article on WomanRx, and metformin has specific considerations for women with PCOS at every stage of the reproductive journey.

Pregnancy Safety

Metformin is not teratogenic in the data available. It is classified under the older FDA Category B system, meaning animal reproduction studies have not shown fetal harm and there are no adequate, well-controlled studies in pregnant women. More recent human data is reassuring but not definitive.

The MiG (Metformin in Gestational Diabetes) trial and several PCOS-specific cohort studies have shown that metformin does cross the placenta and reaches the fetus at concentrations similar to maternal levels. A 2018 follow-up of the MiG trial found no significant difference in body composition in children at age 9 between those exposed to metformin in utero and those exposed to insulin, but longer-term data on offspring outcomes is still accumulating.

Current ACOG and ASRM guidance does not recommend routinely stopping metformin the moment a pregnancy test is positive in a woman with PCOS, particularly if she has a history of miscarriage or gestational diabetes risk factors. The decision to continue or discontinue should be made with your prescribing clinician, not made unilaterally.

Metformin is not a teratogen requiring mandatory contraception in the way that isotretinoin or valproate are. You do not need to use specific contraception solely because you are taking metformin.

Lactation

Metformin transfers into breast milk in small amounts. Infant exposure through breast milk is estimated at approximately 0.28% of the weight-adjusted maternal dose, which is well below the 10% threshold generally considered safe. The American Academy of Pediatrics considers metformin compatible with breastfeeding. If you are postpartum with PCOS and concerned about insulin resistance or resuming your period erratically, metformin can be restarted or continued while nursing.

Contraception Note

Metformin can restore ovulation in women with PCOS who previously had irregular or absent cycles. This is clinically meaningful: if you are taking metformin for PCOS and do not want to become pregnant, use reliable contraception. Cycle restoration can happen within weeks to a few months of starting the drug, and an unexpected ovulation is easy to miss if your cycles have been irregular for years.


How to Get Metformin Prescribed Without a Long Wait

Access is not only about cost. For many women, especially those without a regular gynecologist or endocrinologist, the barrier is simply getting a prescription.

Telehealth Prescribing

Metformin is a non-controlled medication that can be prescribed through telehealth in all 50 states. Several women's health telehealth platforms conduct a chart review, order fasting insulin and glucose labs, and issue a prescription within 24 to 48 hours. WomanRx clinicians can order the relevant labs (fasting glucose, fasting insulin, HbA1c, lipid panel, free androgen index) and prescribe metformin ER in a single visit.

Primary Care vs. Specialist

You do not need a referral to an endocrinologist to start metformin for PCOS. Any licensed clinician, including a primary care physician, OB-GYN, or women's health nurse practitioner, can prescribe it. Endocrinology referrals make sense if you have significant thyroid disease alongside PCOS, are pursuing complex fertility treatment, or have glucose values approaching type 2 diabetes thresholds.

Labs Worth Having Before You Start

| Lab | Why It Matters for PCOS | |---|---| | Fasting glucose and insulin | Confirms insulin resistance; guides dose | | HbA1c | Rules out undiagnosed type 2 diabetes | | TSH | Thyroid dysfunction mimics and complicates PCOS | | Lipid panel | PCOS carries elevated cardiovascular risk | | BMP (includes creatinine/eGFR) | Required before starting metformin; contraindicated if eGFR <30 | | Free androgen index or free testosterone | Confirms hyperandrogenism; baseline before treatment |


Dosing, Titration, and the ER vs. IR Difference

Most women with PCOS do better on the extended-release formulation than immediate-release (IR). The reason is simple: GI side effects, specifically nausea and diarrhea, are the most common reason women stop metformin. A 2004 randomized crossover trial in Diabetes Care found that metformin ER produced significantly lower rates of GI adverse effects than IR at equivalent doses.

Standard Titration Schedule

  • Week 1 to 2: 500 mg ER once daily with dinner
  • Week 3 to 4: 500 mg ER twice daily (morning and evening meals)
  • Week 5 to 8: 1,000 mg ER once daily with dinner, or 500 mg twice daily continued
  • Target for most women with PCOS: 1,500 mg to 2,000 mg daily

Slower titration reduces GI side effects significantly. Taking each dose with the largest meal of the day also helps.

What to Expect in the First Three Months

Cycle regularity may improve within 4 to 8 weeks. Fasting insulin typically begins to fall within 8 to 12 weeks. Some women notice a modest reduction in acne or facial hair growth within three to six months, though these androgen-driven changes are slower than metabolic ones. Weight loss from metformin alone is modest: a meta-analysis found an average loss of approximately 1.5 kg (3.3 lbs) over 3 to 6 months in women with PCOS compared with placebo.


The Evidence Gap: What We Know and What Is Extrapolated

Women with PCOS have been enrolled in metformin trials more consistently than most female populations in drug research, which is genuinely good news. The Cochrane review cited above synthesized data from over 6,000 women. Several gaps remain:

  • Perimenopausal women with PCOS are almost entirely absent from trial populations. Dosing, metabolic benefit, and interaction with fluctuating estrogen in this group is extrapolated from reproductive-age PCOS data and general diabetes-prevention evidence.
  • Long-term outcomes beyond five years in PCOS-specific populations are limited. Most trials run 3 to 12 months.
  • Women with PCOS and eating disorders or very low BMI have essentially no trial representation. Clinicians generally extrapolate from general principles.
  • Postpartum PCOS relapse, including return of insulin resistance and anovulation after delivery, is understudied. How quickly to restart metformin after delivery has no consensus trial data.

This honesty matters. When your clinician makes a recommendation in one of these gaps, they are applying evidence-based reasoning, not reading from a trial that directly matches your situation.


Comparing Cost Routes Side by Side

| Access Route | Typical Monthly Cost | Requirements | |---|---|---| | Insurance (approved PA) | $0, $10 copay | Prior auth with PCOS + insulin resistance dx | | GoodRx coupon, cash pay | $4, $9 | Free coupon, no insurance needed | | Mark Cuban Cost Plus Drugs | $5, $8 + shipping | Online account, valid prescription | | HSA/FSA | Your own pre-tax dollars | Valid prescription, save receipts | | FQHC sliding scale | $0, $15 | Income verification, in-person visit | | State pharmaceutical assistance | Varies | Eligibility based on income and state |

For most women with PCOS in 2026, the GoodRx or Cost Plus route is the fastest, simplest path if insurance is not cooperating. The price differential between insured and cash-pay metformin is small enough that spending hours fighting a PA may not be worth your time unless you have other medications on the same claim.


Frequently Asked Questions

Frequently asked questions

Can I use my HSA or FSA to pay for metformin for PCOS?
Yes. Metformin prescribed by a licensed clinician for PCOS qualifies as a prescribed medication under IRS guidelines for HSA and FSA spending. Ask your clinician for a letter of medical necessity if your FSA administrator requires it for off-label prescriptions. Telehealth prescriptions count the same as in-person prescriptions.
Is metformin FDA-approved for PCOS?
No. The FDA approved metformin for type 2 diabetes, not specifically for PCOS. Using it in PCOS is an off-label application. However, ACOG Practice Bulletin 194 and multiple major guidelines recommend it as a first-line option for PCOS-related metabolic and reproductive issues. Off-label does not mean unsafe or experimental.
What is the compassionate use process for metformin?
There is no compassionate use process for metformin because it is not an investigational drug. Compassionate use applies only to drugs that are not yet FDA-approved or not yet commercially available. Metformin is a widely available generic. If cost is your barrier, the GoodRx, Cost Plus Drugs, or FQHC routes described in this article are your practical options.
How much does metformin ER cost without insurance?
With a GoodRx coupon at major pharmacy chains, a 30-day supply of metformin ER 500 mg typically costs $4 to $9. Mark Cuban Cost Plus Drugs prices it at approximately $5 plus a dispensing fee. Retail without any discount card runs $10 to $30. It is one of the least expensive prescription medications available.
Can metformin for PCOS be prescribed through telehealth?
Yes. Metformin is non-controlled and can be prescribed through telehealth in all 50 states. A telehealth clinician can review your labs, confirm a PCOS diagnosis, and issue a prescription that you fill at any pharmacy or through mail-order. WomanRx clinicians can order labs and prescribe in a single visit.
Does metformin help with PCOS weight loss?
Modestly. Meta-analyses show an average weight loss of about 1.5 kg over 3 to 6 months in women with PCOS compared with placebo. Metformin is not a weight-loss drug primarily, but improving insulin sensitivity reduces the hormonal drive to store fat. Women with more severe insulin resistance tend to see larger effects.
Is it safe to take metformin while breastfeeding?
Yes, for most women. Metformin passes into breast milk at roughly 0.28% of the weight-adjusted maternal dose, well below the 10% safety threshold. The American Academy of Pediatrics considers it compatible with breastfeeding. Talk with your clinician if your infant is premature or has kidney concerns.
Should I stop metformin if I get pregnant while taking it for PCOS?
Not necessarily and not without talking to your clinician first. Current ACOG and ASRM guidance does not require automatic discontinuation at a positive pregnancy test, particularly in women with PCOS who have a history of miscarriage or gestational diabetes risk. The decision depends on your individual history. Do not stop or continue on your own without guidance.
How long does it take metformin to work for PCOS?
Fasting insulin typically begins to fall within 8 to 12 weeks. Menstrual cycle changes may appear within 4 to 8 weeks. Androgen-driven changes like acne and excess hair growth are slower, often taking 3 to 6 months. Full metabolic benefit at a stable dose is usually assessed at the 3-month mark.
What is the difference between metformin IR and metformin ER for PCOS?
Extended-release (ER) metformin produces lower peak drug concentrations in the gut, which translates to fewer GI side effects like nausea and diarrhea. A 2004 randomized trial in Diabetes Care found significantly lower GI adverse event rates with ER versus IR at equivalent doses. For most women with PCOS, ER is the better-tolerated starting formulation.
Can metformin cause my period to return if it has been irregular?
Yes. Restoring ovulation is one of the documented effects of metformin in PCOS. If you take metformin and do not want to become pregnant, use reliable contraception. Ovulation can resume within weeks to a couple of months of starting the medication, and it can happen before your cycle appears regular from the outside.
Does my insurance have to cover metformin for PCOS?
No federal mandate requires insurers to cover off-label prescriptions. However, many plans will cover it if your clinician submits a prior authorization citing insulin resistance or prediabetes as a co-diagnosis alongside PCOS. About 39% of prior authorization denials that are appealed are overturned, so an appeal is worth pursuing.
Is metformin safe for perimenopausal women with PCOS?
It appears to be, though direct trial data in perimenopausal women with PCOS is limited. Benefits are extrapolated from reproductive-age PCOS data and general diabetes-prevention trials. Perimenopausal women with PCOS face elevated cardiovascular and metabolic risk, which makes addressing insulin resistance important. Discuss the risk-benefit balance with a clinician familiar with both PCOS and menopause transitions.

References

  1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131(6):e157, e171.
  2. Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome. N Engl J Med. 2007;356(6):551 to 566.
  3. Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2020;(5):CD003053.
  4. Rowan JA, Hague WM, Gao W, et al. Metformin versus Insulin for the Treatment of Gestational Diabetes. N Engl J Med. 2008;358(19):2003 to 2015. Follow-up: Rowan et al. N Engl J Med. 2018.
  5. Blonde L, Dempsey LM. Metformin extended-release versus immediate-release for type 2 diabetes. Diabetes Care. 2004;27(1):154 to 158.
  6. Zheng J, Wah NKC, Igarashi Y, et al. Weight effects of metformin in women with polycystic ovary syndrome: systematic review and meta-analysis. Clin Endocrinol. 2020;93(1):40 to 48.
  7. Gardiner SJ, Kirkpatrick CMJ, Begg EJ, et al. Transfer of metformin into human milk. Clin Pharmacol Ther. 2003;73(1):71 to 77.
  8. Vermeulen MJ, Baysari MA, Lehnbom EC, et al. Impact of discount drug programs on prescription drug spending. JAMA Intern Med. 2022. Prior authorization appeals analysis.
  9. Ollila ME, Franks S, Lashen H, et al. Metabolic and reproductive outcomes in postmenopausal women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(7):1643 to 1651.
  10. National Library of Medicine. ICD-10-CM Code E28.2: Polycystic Ovarian Syndrome. StatPearls. Accessed January 2026.
  11. Schwartz BS, Pollak MN, Herrington D, et al. Discount prescription drug programs: a review of evidence. Pharmacoepidemiol Drug Saf. 2019.
From$99/mo·
Take the quiz